000807285 000__ 05062cam\a2200553Mi\4500
000807285 001__ 807285
000807285 005__ 20230306143938.0
000807285 006__ m\\\\\o\\d\\\\\\\\
000807285 007__ cr\cn\nnnunnun
000807285 008__ 170812s2017\\\\sz\\\\\\o\\\\\000\0\eng\d
000807285 019__ $$a1000330306$$a1000595074$$a1004988194$$a1011994535$$a1012475006
000807285 020__ $$a9783319565828$$q(electronic book)
000807285 020__ $$a3319565826$$q(electronic book)
000807285 020__ $$z3319565818
000807285 020__ $$z9783319565811
000807285 0247_ $$a10.1007/978-3-319-56582-8$$2doi
000807285 035__ $$aSP(OCoLC)on1000452130
000807285 035__ $$aSP(OCoLC)1000452130$$z(OCoLC)1000330306$$z(OCoLC)1000595074$$z(OCoLC)1004988194$$z(OCoLC)1011994535$$z(OCoLC)1012475006
000807285 040__ $$aEBLCP$$beng$$epn$$cEBLCP$$dYDX$$dN$T$$dGW5XE$$dAZU$$dUPM$$dOCLCQ$$dOCLCO$$dCOO$$dUAB
000807285 049__ $$aISEA
000807285 050_4 $$aR1
000807285 08204 $$a616.07548
000807285 1001_ $$aPiciu, Doina.
000807285 24510 $$aNuclear endocrinology /$$cDoina Piciu.
000807285 250__ $$a2nd ed.
000807285 260__ $$aCham :$$bSpringer,$$c2017.
000807285 300__ $$a1 online resource (304 pages)
000807285 336__ $$atext$$btxt$$2rdacontent
000807285 337__ $$acomputer$$bc$$2rdamedia
000807285 338__ $$aonline resource$$bcr$$2rdacarrier
000807285 347__ $$atext file$$bPDF$$2rda
000807285 500__ $$a6.2.6.4 Technetium-99m (V) DMSA (Tc-99m (V) DMSA).
000807285 5050_ $$aPreface; Note; Contents; Contributors; Introduction; Further Reading; Part I: General Nuclear Medicine; 1: Principles of Nuclear Medicine; 1.1 Principles and History of Nuclear Medicine; 1.2 Basics of Nuclear Physics; 1.2.1 Atomic Structure; 1.2.2 Radioactivity; 1.2.2.1 Radioactive Decay: Alpha Decay (Eq. 1.1); 1.2.2.2 Radioactive Decay: Beta Decay (Eq. 1.3); 1.2.2.3 Radioactive Decay: Gamma Decay (Eq. 1.6); 1.2.2.4 Electron Capture; 1.2.2.5 Decay Equations; 1.2.3 Interaction of Radiation with Matter; 1.2.3.1 Photoelectric Effect; 1.2.3.2 Compton Effect; Further Reading.
000807285 5058_ $$a2: Specific Measurements, Units, and TermsFurther Reading; 3: Dosimetry; 3.1 Decays of Radionuclides and Doses Calculation; 3.1.1 Fluorine F-18; 3.1.2 Gallium Ga-68 and Gallium Ga-67; 3.1.3 Radioiodine I-123; 3.1.4 Radioiodine I-124; 3.1.5 Radioiodine I-125; 3.1.6 Radioiodine I-131; 3.1.7 Indium In-111; 3.1.8 Lutetium Lu-177; 3.1.9 Techentium-99m (Tc-99m); 3.1.10 Thallium Tl-201; 3.1.11 Yttrium Y-90; 3.2 Dose Rates to Target and Critical Organ; Further Reading; 4: The Radiation Protection; 4.1 Basic Factors in Radiation Protection; 4.2 Staff Protection in Nuclear Medicine Units.
000807285 5058_ $$a4.3 General Measures to Reduce the Irradiation of Patient4.4 Physical Factors in Radiation Protection; 4.4.1 Time; 4.4.2 Distance; 4.4.3 Shielding; 4.5 Special Recommendations for Patients Undergoing Nuclear Medicine Procedures; 4.5.1 For Female Patients of Childbearing Age and Breastfeeding; 4.5.2 Procedures in Case of Nuclear Events; 4.5.2.1 Actions for Person Decontamination; 4.5.2.2 Actions for Room Decontamination; Further Reading; 5: Equipments in Nuclear Medicine; 5.1 Gamma Camera; 5.1.1 Collimators; 5.1.2 Crystals; 5.1.3 The Photomultiplier Tubes.
000807285 5058_ $$a5.1.4 Imaging and Processing5.2 Instruments for Thyroid Uptake Evaluation; 5.3 Positron Emission Tomography (PET) and Fusion Images Equipments (PET/CT); 5.4 Whole-Body Counting Systems; 5.5 Gamma Probe Equipment; Further Reading; 6: Radiopharmaceuticals; 6.1 Introduction; 6.2 Radiopharmaceuticals in Endocrinology; 6.2.1 Fluorine-18 Fluorodeoxyglucose (18F-FDG); 6.2.2 Fluorine-18 Fluorocholine (18F-FCH); 6.2.3 Radiopharmaceuticals with Gallium-68 and Gallium-67; 6.2.4 Radiopharmaceuticals with Radioiodine; 6.2.4.1 Radioiodine I-123 Sodium Iodide (I-123 NaI).
000807285 5058_ $$a6.2.4.2 Radioiodine I-124 Sodium Iodide (I-124 NaI)6.2.4.3 Radioiodine I-125 Sodium Iodide (I-125 NaI); 6.2.4.4 Radioiodine I-131 Sodium Iodide (I-131 NaI); 6.2.4.5 Radioiodine I-123 Metaiodobenzylguanidine (I-123 MIBG); 6.2.4.6 Radioiodine I-131 Metaiodobenzylguanidine (I-131 MIBG); 6.2.5 Indium-111 Pentetreotide (In-111 Pentetreotide); 6.2.6 Radiopharmaceuticals with Techentium-99m; 6.2.6.1 Technetium-99m Pertechnetate (Tc-99m Pt); 6.2.6.2 Technetium-99m MIBI (Tc-99m MIBI or Sestamibi); 6.2.6.3 Technetium-99m Tetrofosmin (Tc-99m Tetrofosmin).
000807285 506__ $$aAccess limited to authorized users.
000807285 520__ $$aWith endocrinologists deploying nuclear medicine on a daily basis, and with the rapid development of the latter, this concise and up-to-date guide to the vital information required has been designed to maximize relevance and ease of use in clinical practice.
000807285 588__ $$aDescription based on print version record.
000807285 650_0 $$aRadioisotopes in endocrinology.
000807285 650_0 $$aThyroid gland$$xDiseases$$xDiagnosis.
000807285 650_0 $$aAdrenal glands$$xDiseases$$xDiagnosis.
000807285 650_0 $$aThyroid gland$$xDiseases$$xRadiotherapy.
000807285 77608 $$iPrint version:$$aPiciu, Doina.$$tNuclear Endocrinology.$$dCham : Springer International Publishing, ©2017$$z9783319565811
000807285 852__ $$bebk
000807285 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-56582-8$$zOnline Access$$91397441.1
000807285 909CO $$ooai:library.usi.edu:807285$$pGLOBAL_SET
000807285 980__ $$aEBOOK
000807285 980__ $$aBIB
000807285 982__ $$aEbook
000807285 983__ $$aOnline
000807285 994__ $$a92$$bISE